Oricula Therapeutics LLC
Biotechnology company · Seattle, Washington, United States
Oricula Therapeutics LLC is a biotechnology company headquartered in Seattle, Washington, United States. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $2.2 million in total, most recently in 2016.
Oricula Therapeutics at a glance
What does Oricula Therapeutics do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $2.2 million in total (2014 to 2016). NIH funding came from the National Institute of Allergy and Infectious Diseases.
Frequently asked questions about Oricula Therapeutics
Where is Oricula Therapeutics headquartered?
Oricula Therapeutics LLC is headquartered in Seattle, Washington, United States.
What does Oricula Therapeutics do?
Oricula Therapeutics LLC is a biotechnology company.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Phase Genomics, Inc.Seattle, Washington, United States
- Soovu Labs, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences